Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal MET Amplification from Aneuploidy in Diverse Advanced Cancers

por Kumaki, Yuichi, Olsen, Steve, Suenaga, Mitsukuni, Nakagawa, Tsuyoshi, Uetake, Hiroyuki, Ikeda, Sadakatsu
Publicado 2021

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice

por Cho, Byoung Chul, Loong, Herbert H. F., Tsai, Chun-Ming, Teo, Man Lung P., Kim, Hye Ryun, Lim, Sun Min, Jain, Suyog, Olsen, Steve, Park, Keunchil
Publicado 2022

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Ad...

por Raphael, Ari, Dudnik, Elizabeth, Hershkovitz, Dov, Jain, Suyog, Olsen, Steve, Soussan-Gutman, Lior, Ben-Shitrit, Taly, Dvir, Addie, Nechushtan, Hovav, Peled, Nir, Onn, Amir, Agbarya, Abed
Publicado 2022

Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors

por Kwon, Minsuk, Ku, Bo mi, Olsen, Steve, Park, Sehhoon, Lefterova, Martina, Odegaard, Justin, Jung, Hyun‐Ae, Sun, Jong‐Mu, Lee, Se‐Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung‐Ju
Publicado 2022

Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial

por Nakamura, Yoshiaki, Okamoto, Wataru, Kato, Takeshi, Esaki, Taito, Kato, Ken, Komatsu, Yoshito, Yuki, Satoshi, Masuishi, Toshiki, Nishina, Tomohiro, Ebi, Hiromichi, Sawada, Kentaro, Taniguchi, Hiroya, Fuse, Nozomu, Nomura, Shogo, Fukui, Makoto, Matsuda, Seiko, Sakamoto, Yasutoshi, Uchigata, Hiroshi, Kitajima, Kana, Kuramoto, Naomi, Asakawa, Takashi, Olsen, Steve, Odegaard, Justin I., Sato, Akihiro, Fujii, Satoshi, Ohtsu, Atsushi, Yoshino, Takayuki
Publicado 2021